Prediction of overall survival with 2nd-line (L2OS) chemotherapy (CT) in patients with advanced biliary tract cancer (aBTC): AGEO CT2BIL cohort update and international multicenter external validations

Affiliation auteurs!!!! Error affiliation !!!!
TitrePrediction of overall survival with 2nd-line (L2OS) chemotherapy (CT) in patients with advanced biliary tract cancer (aBTC): AGEO CT2BIL cohort update and international multicenter external validations
Type de publicationJournal Article
Year of Publication2018
AuteursNeuzillet C., A. Gardini C, Brieau B., Vivaldi C., Smolenschi C., Brandi G., Tougeron D., Filippi R., Vienot A., Silvestris N., Pointet A-L., Murgioni S., Rousseau C., Scartozzi M., Dahan L., Boussaha T., Crusz S., Meurisse A., Lievre A., Vernerey D.
JournalANNALS OF ONCOLOGY
Volume29
Date PublishedOCT
Type of ArticleMeeting Abstract
ISSN0923-7534